Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Language
Publication year range
1.
J Mater Chem B ; 11(28): 6478-6490, 2023 07 19.
Article in English | MEDLINE | ID: mdl-37326239

ABSTRACT

High temperature generated by photothermal therapy (PTT) can trigger an inflammatory response at the tumor site, which not only limits the efficacy of PTT but also increases the risk of tumor metastasis and recurrence. In light of the current limitations posed by inflammation in PTT, several studies have revealed that inhibiting PTT-induced inflammation can significantly improve the efficacy of cancer treatment. In this review, we summarize the research progress made in combining anti-inflammatory strategies to enhance the effectiveness of PTT. The goal is to offer valuable insights for developing better-designed photothermal agents in clinical cancer therapy.


Subject(s)
Hyperthermia, Induced , Neoplasms , Humans , Photothermal Therapy , Phototherapy , Neoplasms/drug therapy , Neoplasms/pathology , Inflammation/drug therapy , Anti-Inflammatory Agents
3.
Chem Commun (Camb) ; 55(41): 5817-5820, 2019 May 16.
Article in English | MEDLINE | ID: mdl-31041939

ABSTRACT

A novel Au-Se nanoprobe with remarkable anti-interference ability for glutathione was developed for real-time in situ monitoring of the upstream and downstream regulatory relationship between uPA and MMP-9 proteins in the pathway.


Subject(s)
Gold/chemistry , Matrix Metalloproteinase 9/analysis , Nanostructures/chemistry , Neoplasms/diagnostic imaging , Optical Imaging/methods , Selenium/chemistry , Urokinase-Type Plasminogen Activator/analysis , Glutathione/chemistry , Humans , MCF-7 Cells , Nanostructures/ultrastructure , Neoplasms/enzymology
4.
Angew Chem Int Ed Engl ; 58(4): 1057-1061, 2019 01 21.
Article in English | MEDLINE | ID: mdl-30397990

ABSTRACT

The development of highly effective anticancer drugs that cause minimal damage to the surrounding normal tissues is a challenging topic in cancer therapy. Herein, we demonstrate a dual-targeted organic molecule that functions as a photothermal agent by actively targeting tumor tissue and mitochondria to selectively kill cancer cells. The synthesized photothermal agent exhibited high photothermal conversion efficiency, low cytotoxicity, and good biological compatibility. In vivo experiments showed an excellent tumor inhibitory effect of the dual-targeted photothermal agent.


Subject(s)
Antineoplastic Agents/chemical synthesis , Hyperthermia, Induced/methods , Phototherapy/methods , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Cell Survival/drug effects , Cell Survival/radiation effects , Humans , Mice , Molecular Structure , Xenograft Model Antitumor Assays
SELECTION OF CITATIONS
SEARCH DETAIL